Wednesday
SESSION 32: DRUG RESISTANT HYPERTENSION AND ITS CATHETER-BASED TREATMENTS; MEDICAL TREATMENTS; FRACTIONAL FLOW RESERVE; ASSESSMENT OF AAA RISK; UNUSUAL VASCULAR DISEASES
SESSION 32 SCHEDULE
7:46 AM - 7:51 AM Why Pharmacological Treatments Are Insufficient To Control Hypertension In Some Patients And What Is The Outlook For Non-Pharmacologic Treatments; Renal Denervation And Baroreflex Stimulation (Neostim) And Modulation (Mobius)
  Presenter(s):Melvin D. Lobo, MBChB , PhD, FRCP, FBHS, FESC  
  View Slides in PDF      
7:52 AM - 7:57 AM What Is New With Endovascular Treatments Of Drug Resistant Hypertension: New Better Devices Like The Peregrine And Paradise Systems For Renal Denervation: New Study Results: Future Predictions
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM Renal Artery Denervation For Hypertension: Why Hasnít It Worked And Where Is It Going
  Presenter(s):Krishna J. Rocha-Singh, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM Update On The ROX Endovascular System For Creating An Iliac A-V Fistula To Treat Resistant Hypertension: How It Works, Results And Complications
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
8:10 AM - 8:15 AM Diagnostic Strategy For Children With Suspected Renin Mediated Hypertension Is Multimodal: Is Endovascular Treatment Ever Effective
  Presenter(s):Kyung Cho, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Whatís New In The Pharmacologic Prevention And Treatment In Patients With Arteriosclerotic Vascular Disease Ė Where Are We Currently With Statins, PCSK 9 Inhibitors And Platelet Inhibitors
  Presenter(s):Iris Baumgartner, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM Update On The Value Of Coronary CT And Fractional Flow Reserve (FFRct): Does It Eliminate Unnecessary Coronary Angiograms And Stents; Will The Technique Work In The Lower Extremity
  Presenter(s):Christopher K. Zarins, MD  
  View Slides in PDF      
8:28 AM - 8:33 AM How Skin Biopsy Can Predict AAA Growth Rates And Rupture
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
8:34 AM - 8:39 AM Systemic Inflammatory Disease: What Is It And How To Diagnose It: Does It Predict Increase Risk Of Post EVAR Complications, Type 2 Endoleak And Rupture
  Presenter(s):Alan Dardik, MD, PhD  
  View Slides in PDF      
8:40 AM - 8:45 AM Segmental Arterial Mediolysis: What Is It; What Is Its Clinical Significance; How To Diagnose And Treat It
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
8:46 AM - 8:54 AM Panel Discussion
END OF SESSION 32
previous next